Business

Suspension of Trading

Suspension of Trading.

articleEmergent Health Corp.September 30, 20093/company/emergent-health-corp/news/suspension-of-trading-25
Suspension of Trading

About this update from Emergent Health Corp.

[{"type":"text","content":"UNITED STATES OF AMERICAst1\\:*{behavior:url(#ieooui) }UNITED STATES OF AMERICABefore the SECURITIES AND EXCHANGE COMMISSIONSECURITIES EXCHANGE ACT OF 1934Release No. 60745 / September 30, 2009 The Securities and Exchange Commission (“Commission”) announced the temporary suspension, pursuant to Section 12(k) of the Securities Exchange Act of 1934 (the \"Exchange Act\"), of trading in the securities of Emergent Health Corp. (\"Emergent\"), of King of Prussia, Pennsylvania at 9:30 a.m. on September 30, 2009, and terminating at 11:59 p.m. on October 13, 2009.  The Commission temporarily suspended trading in the securities of Emergent because questions have arisen regarding the company’s issuance of stock and trading in the company’s stock.  The Commission cautions broker-dealers, shareholders, and prospective purchasers that they should carefully consider the foregoing information along with all other currently available information and any information subsequently issued by the company.  Further, brokers and dealers should be alert to the fact that, pursuant to Rule 15c2-11 under the Exchange Act, at the termination of the trading suspension, no quotation may be entered unless and until they have strictly complied with all of the provisions of the rule. If any broker or dealer has any questions as to whether or not he has complied with the rule, he should not enter any quotation but immediately contact the staff in the Division of Trading and Markets, Office of Interpretation and Guidance, at (202) 551­5777. If any broker or dealer is uncertain as to what is required by Rule 15c2-11, he should refrain from entering quotations relating to Emergent securities until such time as he has familiarized himself with the rule and is certain that all of its provisions have been met. If any broker or dealer enters any quotation which is in violation of the rule, the Commission will consider the need for prompt enforcement action.  If any broker-dealer or other person has any information which may relate to this matter, should immediately contact Eric R. Busto, Assistant Regional Director, Miami Regional Office of the Securities and Exchange Commission at (305) 982-6362.","length":5699,"tagName":"div"}]

More updates from Emergent Health Corp.